I should say I meant "Regular CR" in the future, as clearly their revenue doesn't cover their expense.
Undervalued small-cap tech or Bio companies all have in common: potential earning and revenue outlook, which USCOM doesn't have.
Respect your long last, consistent interest and believe in this one, just to point out something which someone in love may not choose to see.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.861M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 250000 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 42000 | 1 |
View Market Depth
| Last trade - 16.21pm 25/07/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable